FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
+3.35%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
AUM
$1.3B
AUM Growth
+$1.3B
Cap. Flow
+$156M
Cap. Flow %
11.99%
Top 10 Hldgs %
55.9%
Holding
47
New
6
Increased
12
Reduced
2
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TYRA icon
26
Tyra Biosciences
TYRA
$675M
$17.6M 1.35% 1,250,000
KALV icon
27
KalVista Pharmaceuticals
KALV
$678M
$17.3M 1.33% 1,305,087 +1,148,280 +732% +$15.2M
TCDA
28
DELISTED
Tricida, Inc. Common Stock
TCDA
$17.1M 1.31% +1,783,893 New +$17.1M
COGT icon
29
Cogent Biosciences
COGT
$1.69B
$15.2M 1.17% +1,774,891 New +$15.2M
FLACU
30
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$14.9M 1.15% 1,501,000
ARVN icon
31
Arvinas
ARVN
$568M
$13.5M 1.04% +163,763 New +$13.5M
GRCL
32
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$10M 0.77% 1,654,938 +803,300 +94% +$4.85M
EPIX icon
33
ESSA Pharma
EPIX
$11.4M
$7.72M 0.59% 543,470 +185,124 +52% +$2.63M
RGNX icon
34
Regenxbio
RGNX
$451M
$7.71M 0.59% 235,809
AVDL
35
Avadel Pharmaceuticals
AVDL
$1.43B
$7.69M 0.59% 951,814
ACRS icon
36
Aclaris Therapeutics
ACRS
$209M
$5.94M 0.46% 408,329
MTEM
37
DELISTED
Molecular Templates, Inc.
MTEM
$5.39M 0.41% 1,374,047
APTX
38
DELISTED
Aptinyx Inc. Common Stock
APTX
$5.03M 0.39% 1,883,244
IMVT icon
39
Immunovant
IMVT
$2.56B
$4.99M 0.38% 585,759
SRRK icon
40
Scholar Rock
SRRK
$3.14B
$3.88M 0.3% 156,000
EPZM
41
DELISTED
Epizyme, Inc
EPZM
$1.85M 0.14% 739,369
ALNA
42
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$978K 0.08% 1,651,357 -1,679,016 -50% -$994K
NBRV
43
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$255K 0.02% 425,650
GRTX
44
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-241,000 Closed -$1.95M
FRLN
45
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
-550,000 Closed -$1.88M
BLU
46
DELISTED
BELLUS Health Inc.
BLU
-433,247 Closed -$2.65M
TRIL
47
DELISTED
Trillium Therapeutics Inc.
TRIL
-3,123,107 Closed -$55M